13F Holdings
中文EN

IMCC IM Cannabis Corp. IFRS

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1792030 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY1.3%
TTM net income YoY-6.9%
TTM EPS YoY—
Revenue 3-yr CAGR0.2%
Net income 3-yr CAGR—

Margins

Gross margin17.7%
Operating margin-21.2%
Net margin-20.7%
FCF margin8.6%
EBITDA margin—

Returns

ROE-1,496.2%
ROA-31.9%
ROIC (approx.)-63.6%
Asset turnover1.54x

Leverage & solvency

Liabilities / assets111.4%
Debt / equity—
Current ratio0.67x
Interest coverage-3.31x

Cash quality & payout

Operating cash flow / net income-0.42x
Accruals ratio-45.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: CAD 2025Q22025-06-302024Q22024-06-302023Q22023-06-302022Q22022-06-302021Q22021-06-30
Income statement
Revenue12.70M14.75M13.21M12.70M11.11M
Cost of revenue9.27M13.91M9.47M10.11M10.51M
Gross profit3.42M844,0003.46M2.20M-568,000
SG&A expense2.48M2.16M2.39M3.34M7.47M
Operating income-350,000-2.87M-1.75M-5.62M-10.72M
Interest expense1.76M1.46M2.11M2.20M543,000
Pretax income-220,000-4.29M-3.87M-4.71M-5.05M
Income tax-26,000-839,000-160,000-1.01M37,000
Net income-309,000-3.03M-3.46M-18.66M-4.63M
EBITDA—-2.36M-974,000-4.78M—
EPS (basic)-0.09-1.36-0.26-2.72-0.10
EPS (diluted)-0.09-1.36-0.26-3.12-0.23
Weighted avg. shares (diluted)———71.71M45.62M
Balance sheet
Cash & equivalents794,000700,0001.32M5.86M34.05M
Receivables12.52M3.65M3.40M6.17M—
Inventory3.66M5.72M14.48M26.65M—
Current assets25.44M22.94M30.40M63.32M—
PP&E, netmay include right-of-use assets (IFRS)3.81M4.05M5.24M22.67M—
Goodwill6.86M6.63M9.10M117.22M—
Intangibles2.82M3.68M6.57M26.72M—
Total assets41.07M40.22M55.75M255.31M—
Current liabilities35.15M33.40M28.11M53.56M—
Short-term debt13.32M12.75M11.48M18.00M—
Long-term debt1.30M401,000379,000354,000—
Total debt14.62M13.15M11.86M18.36M—
Total liabilities37.01M34.73M34.21M75.76M—
Shareholders' equity3.52M7.07M20.91M177.56M143.63M
Net debt13.83M12.45M10.54M12.49M—
Shares outstanding4.04M13.39M13.39M69.70M—
Cash flow statement
Operating cash flow—————
Depreciation & amortization—511,000778,000847,000—
Stock-based compensation4,00088,000-137,000732,0001.37M

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.